Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 12 Neoplasms 11 Cancer Pain 8 Neuralgia 2 Inflammation 2 Head and Neck Neoplasms 2 Bronchiolitis Obliterans Syndrome 2 Agnosia 2 Urinary Tract Infections 1 Trigger Finger Disorder 1 Stomatitis 1 Staphylococcal Infections 1 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1 Squamous Cell Carcinoma of Head and Neck 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Osteoarthritis 1 Nutrition Disorders 1 Non Cancer Pain 1 Neutropenia 1 Nasopharyngeal Carcinoma 1 Multiple Pulmonary Nodules 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Non Cancer Pain × Oxycodone × Clear all

NCT01918098 2017-11-14

Targin for Non-cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed

Non Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡